BD has announced a collaboration with Hamilton to develop automated applications for high-throughput, single-cell multiomics experiments.

The partnership aims to standardise the single-cell multiomics experiments and reduce human error in the preparation of DNA samples or ‘libraries’ ready for genetic sequencing.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

These multiomics experiments are said to be crucial for gaining insights from cells, with the construction of genetic libraries being the first step.

However, the process of next-generation sequencing (NGS) library preparation is traditionally manual, time-consuming and prone to inconsistency.

The collaboration between BD and Hamilton seeks to address these challenges by automating steps such as pipetting and thermal cycling.

BD Biosciences worldwide president Steve Conly said: “Multiomics-based assays are increasingly used by single cell researchers in the fields of oncology, immunology and other disciplines to help investigate the various layers of information on a single cell and access a deeper view of health and disease, which is why ensuring reproducible results is critical.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

“By integrating Hamilton’s robotic technology into our end-to-end portfolio of single-cell multiomics solutions, BD continues to leverage automation so that more researchers – whether academic, biopharmaceutical or contract research organisation – are empowered to perform larger-scale single-cell multiomics studies with confidence.”

The company aims to deliver a suite of Rhapsody Single-Cell Analysis Library Preparation Reagent Kits to perform on the Hamilton Microlab NGS STAR robotic liquid-handling platform.

Hamilton vice-CEO Matt Hamilton said: “Through this collaboration with BD, we aim to deliver a complete solution for researchers that reduces the potential for biases and enables greater throughput so that labs can achieve their results with greater reliability.”

The BD Rhapsody Single-Cell Analysis Library Preparation Reagent Kits and Hamilton Microlab NGS STAR applications are due to be released in phases, beginning this year.

……………………

PR/Image                                    

https://news.bd.com/2024-01-23-BD,-Hamilton-Collaborate-to-Standardize-Single-Cell-Multiomics-Experiments-Using-Robotics

Image

https://mma.prnewswire.com/media/2324283/BD_Hamilton_Collaboration.jpg?w=2700

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact